Experimental testing and modelling to improve the resilience of buildings with concrete walls during earthquakes

Autor: RS Henry, JM Ingham

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f81017fd593b566d7b28d1fc8e787b37

Visual compatibility of 30 additives with a parenteral nutrient solution

Autor: N Athanikar, Raymond W. Jurgens, A Welco, R Sturgeon, H Harbison, C Mett, M VanLeuven, RS Henry, B Boyer, R Deamer

Publikováno v: American Journal of Health-System Pharmacy. 36:511-513

The visual compatibility of 30 drug additives with total parenteral nutrient (TPN) solutions (4.25% amino acids, 25% dextrose injection) was studied. For each drug additive, three TPN solutions were mixed; two were stored for 22 hours at 4 C then all

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e715e636ac9f769fe625371ad9ee582
https://doi.org/10.1093/ajhp/36.4.511

Compatibility of Calcium Chloride and Calcium Gluconate with Sodium Phosphate in a Mixed TPN Solution

Autor: R Sturgeon, A Welco, M Van Leuven, Raymond W. Jurgens, N Athanikar, RS Henry

Publikováno v: American Journal of Health-System Pharmacy. 37:673-674

The maximum concentrations of phosphate that will remain soluble in a parenteral nutrient solution containing various concentrations of calcium chloride or calcium gluconate were determined. Various concentrations of sodium phosphate were mixed with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef89230768504b8632d08c905dc698d6
https://doi.org/10.1093/ajhp/37.5.673

Minimal Detectable Changes of the Health Assessment Questionnaire-Disability Index, Patient-Reported Outcomes Measurement Information System-29 Profile Version 2.0 Domains, and Patient Health Questionnaire-8 in People With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Cross-Sectional Study.

Autor: Alkan A; Lady Davis Institute for Medical Research and McGill University, Montreal, Quebec, Canada, and Ankara Yildirim Beyazit University, Ankara, Turkey., Carrier ME; Lady Davis Institute for Medical Research, Montreal, Quebec, Canada., Henry RS; Lady Davis Institute for Medical Research and McGill University, Montreal, Quebec, Canada., Kwakkenbos L; Radboud University and Radboud University Medical Center, Nijmegen, The Netherlands., Bartlett SJ; McGill University and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Gietzen A; National Scleroderma Foundation, Buffalo, New York., Gottesman K; National Scleroderma Foundation, Los Angeles, California., Guillot G; Sclérodermie Québec, Longueuil, Quebec, Canada., Lawrie-Jones A; Scleroderma Australia, Melbourne, Victoria, Australia., Hudson M; Lady Davis Institute for Medical Research and McGill University, Montreal, Quebec, Canada., Hummers LK; Johns Hopkins University School of Medicine, Baltimore, Maryland., Malcarne VL; San Diego State University, San Diego, California., Mayes MD; University of Texas McGovern School of Medicine, Houston., Mouthon L; Hôpital Cochin and Université Paris Cité, Paris, France., Richard M; Scleroderma Atlantic, Halifax, Nova Scotia, Canada., Wojeck RK; University of Rhode Island, Kingston., Worron-Sauvé M; Scleroderma Society of Ontario, Hamilton, Ontario, Canada., Benedetti A; McGill University and McGill University Health Centre, Montreal, Quebec, Canada., Thombs BD; Lady Davis Institute for Medical Research and McGill University, Montreal, Quebec, Canada.

Publikováno v: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Nov; Vol. 76 (11), pp. 1549-1557. Date of Electronic Publication: 2024 Aug 27.

Changes in work and adequacy of financial resources during COVID-19 among people with systemic sclerosis: A Scleroderma Patient-centered Intervention Network study.

Autor: Adams C; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Psychiatry, McGill University, Montreal, QC, Canada., Nassar EL; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Psychology, McGill University, Montreal, QC, Canada., Carrier ME; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Kwakkenbos L; Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.; Department of IQ Health, Radboud University Medical Center, Nijmegen, The Netherlands.; Centre for Mindfulness, Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands., Henry RS; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Psychiatry, McGill University, Montreal, QC, Canada., Virgili-Gervais G; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Hu S; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Bartlett SJ; Department of Medicine, McGill University, Montreal, QC, Canada.; The Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Fortuné C; Ottawa Scleroderma Support Group, Ottawa, ON, Canada., Gietzen A; National Scleroderma Foundation, Tri-State Chapter, Binghamton, NY, USA., Gottesman K; National Scleroderma Foundation, Los Angeles, CA, USA., Guillot G; Sclérodermie Québec, Montreal, QC, Canada., Hudson M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Medicine, McGill University, Montreal, QC, Canada., Lawrie-Jones A; Scleroderma Australia, Melton, VIC, Australia.; Scleroderma Victoria, Fitzroy, VIC, Australia., Lewis N; The Scleroderma Patient-centered Intervention Network, Montreal, QC, Canada., Malcarne V; Department of Psychology, San Diego State University, San Diego, CA, USA.; San Diego State University and University of California, San Diego, CA, USA., Mayes MD; University of Texas McGovern School of Medicine, Houston, TX, USA., Patten SB; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.; O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada., Richard M; Scleroderma Atlantic, Halifax, NS, Canada., Sauvé M; Scleroderma Society of Ontario, Hamilton, ON, Canada.; Scleroderma Canada, Hamilton, ON, Canada., Varga J; Division of Rheumatology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA., Welling J; NVLE Dutch patient organization for systemic autoimmune diseases, Utrecht, The Netherlands., Wojeck R; The University of Rhode Island, Kingston, RI, USA., Mouthon L; Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Service de Médecine Interne, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; APHP-CUP, Hôpital Cochin, Université de Paris, Paris, France., Benedetti A; Department of Medicine, McGill University, Montreal, QC, Canada.; The Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, QC, Canada., Thombs BD; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Psychiatry, McGill University, Montreal, QC, Canada.; Department of Psychology, McGill University, Montreal, QC, Canada.; Department of Medicine, McGill University, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.

Publikováno v: Journal of scleroderma and related disorders [J Scleroderma Relat Disord] 2024 Oct; Vol. 9 (3), pp. 242-247. Date of Electronic Publication: 2024 Aug 05.